After we identified the activation of GP130, IL-11, IL-11Rα and STAT3 expression in human colon cancer cells, we confirmed that the neutralized GP130 antibody could reduce the viability of human colon cancer cells. The gene discussed is IL11; the disease is colonic neoplasm.